Skip to content

Clinical trials

Completed Muscular Dystrophy, Duchenne trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Status: Completed Country / region: Australia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20103
20121
20131
20163
20173
20182
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics4
ReveraGen BioPharma, Inc.4
Cooperative International Neuromuscular Research Group2
Novartis Pharmaceuticals2
Catabasis Pharmaceuticals1
Edgewise Therapeutics, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
NS Pharma, Inc.1
Sarepta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne19
Muscular Dystrophies7
Neuromuscular Diseases4
Musculoskeletal Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2
Osteoporosis2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.